| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| NOTCH1 | HOT NO1-H52H3 | Human NOTCH1 Protein, His Tag, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 100ug | |
| NOTCH1 | Human NOTCH1 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 100ug | ||
| NOTCH1 | Biotinylated Human NOTCH1 Protein, Fc Tag, ultra sensitivity (primary amine labeling) | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| NOTCH1 | Mouse NOTCH1 Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $360.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Crenigacestat | JSMD-194; LY-3039478; BMS-986405 | Phase 1 Clinical | Eli Lilly And Company | Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Leiomyosarcoma; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Multiple Myeloma; Neoplasm Metastasis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Solid tumours; Triple Negative Breast Neoplasms | Details |